Future Horizons in the German Infectious Disease TestingMarket: Supplier Shares and Sales Forecasts for 100 Tests byMarket...
A. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. ...
11. Candidaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb...
22. Ebola Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines...
b. Diagnostic Testsc. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines an...
b. Diagnostic Testsc. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs44. Mononuc...
53. Respiratory Syncytial Virus (RSV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Backgroundb. ...
b. Diagnostic Testsc. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. ...
B. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development Opportunitie...
- Enzo Biochem- Fujirebio- Gen-Probe- Hologic- ID Biomedical- Innogenetics/Solvay- Kreatech- Life Technology- Lonza- Nanog...
Major Companies Developing or Marketing EchovirusTestsMajor Companies Developing or Marketing EnterovirusTestsMajor Compan...
Major Companies Developing or Marketing PneumoniaTestsMajor Companies Developing or Marketing RSV TestsMajor Companies Dev...
All Market Segments Infectious Disease Test Volume ForecastGermanyHospital Laboratories Infectious Disease Test Volume For...
GermanyCampylobacter Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCandida Test Volume and Diagnostics...
by Market SegmentGermanyGiardia Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyGonorrhea Test Volume an...
GermanyHBcAg Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHBeAg Test Volume and Diagnostics Sales For...
by Market SegmentGermanyMononucleosis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMumps Test Volume ...
Salmonella Test Volume and Diagnostics Sales Forecastby Market SegmentGermanySepticemia Test Volume and Diagnostics Sales ...
GermanyCandida Testing Market Diagnostics Salesby Major SupplierGermanyCMV Testing Market Diagnostics Sales by Major Suppl...
Rotavirus Testing Market Diagnostics Salesby Major SupplierGermanyRubella Testing Market Diagnostics Salesby Major Supplie...
Upcoming SlideShare
Loading in …5
×

Future Horizons in the German Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment

164 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
164
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Future Horizons in the German Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment

  1. 1. Future Horizons in the German Infectious Disease TestingMarket: Supplier Shares and Sales Forecasts for 100 Tests byMarket SegmentReport Details:Published:August 2012No. of Pages: 983Price: Single User License – US$5900Highlights•Comprehensive 983-page analysis of the German microbiology testing market.•Major issues pertaining to the German microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.•Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in German hospitals, blood banks and commercial laboratories.•Instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 983 pages and 160 tablesGet your copy of this report @http://www.reportsnreports.com/reports/187750-future-horizons-in-the-german-infectious-disease-testing-market-supplier-shares-and-sales-forecasts-for-100-tests-by-market-segment.htmlMajor points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology Overview
  2. 2. A. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Tests0 Identification from Culturec. Vaccines and Drugs
  3. 3. 11. Candidaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs15. Clostridium Difficilea. Backgroundb. Diagnostic Testsc. Drugs and Vaccines16. Coronavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs17. Coxsackievirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs18. Creutzfeldt-Jakob’s Diseasea. Backgroundb. Diagnostic Testsc. Vaccines19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  4. 4. 22. Ebola Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs24. EchoVirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs25. Encephalitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs26. Enterovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs27. Epstein-Barr Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs28. Giardia Lambliaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs32. Helicobacter Pyloria. Background
  5. 5. b. Diagnostic Testsc. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines and Drugs34. Herpes Simplex Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs35. Human Herpes Virus-6 (HHV-6)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs42. Meningitisa. Background
  6. 6. b. Diagnostic Testsc. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs44. Mononucleosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs46. Mycoplasmaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  7. 7. 53. Respiratory Syncytial Virus (RSV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs55. RotaVirus (REOVIRUS)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs56. Rubella(MEASLES)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs57. Salmonellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs58. Septicemiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs59. Shigellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs60. Staphylococcus Aureusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs61. Streptococcia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs62. Syphilisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs63. Toxoplasmosisa. Background
  8. 8. b. Diagnostic Testsc. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs68. Yersinaa. Backgroundb. Diagnostic Testsc. Vaccines and DrugsB. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherGermanyA. Executive Summary
  9. 9. B. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/PanelsC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for DecentralizedTesting Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Assessments- Abbott- Affymetrix- Beckman Coulter/Danaher- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical
  10. 10. - Enzo Biochem- Fujirebio- Gen-Probe- Hologic- ID Biomedical- Innogenetics/Solvay- Kreatech- Life Technology- Lonza- Nanogen/Elitech- Novartis Diagnostics- Ortho-Clinical Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher- Wallac- WakoList of TablesMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing AdenovirusTestsMajor Companies Developing or Marketing BartonellaTestsMajor Companies Developing or MarketingCampylobacter TestsMajor Companies Developing or Marketing CandidaTestsMajor Companies Developing or Marketing ChlamydiaTestsMajor Companies Developing or Marketing ClostridiumTestsMajor Companies Developing or Marketing CoronavirusTestsMajor Companies Developing or Marketing CryptosporidiumTestsMajor Companies Developing or Marketing CMV Tests
  11. 11. Major Companies Developing or Marketing EchovirusTestsMajor Companies Developing or Marketing EnterovirusTestsMajor Companies Developing or Marketing EBV TestsMajor Companies Developing or Marketing GiardiaTestsMajor Companies Developing or Marketing GonorrheaTestsMajor Companies Developing or Marketing HantavirusTestsMajor Companies Developing or Marketing HelicobacterPylori TestsMajor Companies Developing or Marketing HepatitisTestsMajor Companies Developing or Marketing HerpesTestsMajor Companies Developing or Marketing InfluenzaTestsMajor Companies Developing or Marketing LegionellaTestsMajor Companies Developing or Marketing Lyme DiseaseTestsMajor Companies Developing or Marketing LymphogranulomaTestsMajor Companies Developing or Marketing MalariaTestsMajor Companies Developing or Marketing MeaslesTestsMajor Companies Developing or Marketing MeningitisTestsMajor Companies Developing or Marketing MicrosporidiumTestsMajor Companies Developing or MarketingMononucleosis TestsMajor Companies Developing or Marketing Mumps TestsMajor Companies Developing or Marketing MycoplasmaTestsMajor Companies Developing or Marketing PapillomaVirus TestsMajor Companies Developing or Marketing ParvovirusTests
  12. 12. Major Companies Developing or Marketing PneumoniaTestsMajor Companies Developing or Marketing RSV TestsMajor Companies Developing or Marketing RotavirusTestsMajor Companies Developing or Marketing RubellaTestsMajor Companies Developing or Marketing SalmonellaTestsMajor Companies Developing or Marketing SepticemiaTestsMajor Companies Developing or Marketing ShigellaTestsMajor Companies Developing or Marketing StaphylococciTestsMajor Companies Developing or MarketingStreptococci TestsMajor Companies Developing or Marketing SyphilisTestsMajor Companies Developing or Marketing ToxoplasmosisTestsMajor Companies Developing or Marketing TrichomonasTestsMajor Companies Developing or Marketing TuberculosisTestsMajor Companies Developing or Marketing West NileTestsMajor Companies Developing or Marketing Yersinia TestsGermany Summary TableAll Infectious Diseases Test Volume and DiagnosticsSales Forecast by Market SegmentGermanyLaboratories Performing Infectious Disease TestsForecast by Market SegmentGermanyHospital Laboratories Performing Infectious DiseaseTests by Bed SizeGermanyCommercial/Private Laboratories Performing InfectiousDisease Tests by Annual Test VolumeGermany
  13. 13. All Market Segments Infectious Disease Test Volume ForecastGermanyHospital Laboratories Infectious Disease Test Volume ForecastGermanyBlood Banks Infectious Disease Test Volume ForecastGermanyCommercial/Private Laboratories Infectious DiseaseTest Volume ForecastGermanyAll Market Segments Infectious Disease DiagnosticsMarket ForecastGermanyHospital Laboratories Infectious Disease DiagnosticsMarket ForecastGermanyBlood Banks Infectious Disease Diagnostics Market ForecastGermanyCommercial/Private Laboratories Infectious DiseaseDiagnostics Market ForecastGermanyHIV or HIV I/HIVII Test Volume and Diagnostics SalesForecast by Market SegmentGermanyHIV Ag Test Volume and Diagnostics Sales Forecast by MarketSegmentGermanyWestern Blot/Other Confirmatory Test Volume andDiagnostics Sales Forecast by Market SegmentGermanyAdenovirus Test Volume and Diagnostics Sales Forecast byMarket SegmentGermanyAeromonads Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyBEA Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyBlastocystis Hominis Test Volume and DiagnosticsSales Forecast by Market Segment
  14. 14. GermanyCampylobacter Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCandida Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyChancroid Test Volume and Diagnostics Sales Forecast by MarketSegmentGermanyChlamydia Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyClostridium Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCoxsackieVirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCryptosporidium Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCyclospora Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCMV Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyE. Coli Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyEchovirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyEncephalitis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyEnterovirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyEBV Test Volume and Diagnostics Sales Forecast
  15. 15. by Market SegmentGermanyGiardia Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyGonorrhea Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyGranuloma Inguinale Test Volume and Diagnostics SalesForecast by Market SegmentGermanyHantavirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHelicobacter Pylori Test Volume and DiagnosticsSales Forecast by Market SegmentGermanyHAV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHBV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHBsAg Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHepatitis C Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyAnti-HBc Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyAnti-HBs Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyAnti-HAV Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHepatitis Delta Test Volume and Diagnostics SalesForecast by Market Segment
  16. 16. GermanyHBcAg Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHBeAg Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyALT/SGPT Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHerpes Simplex I and II Test Volume and DiagnosticsSales Forecast by Market SegmentGermanyHerpes Type VI Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyHTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market SegmentGermanyInfluenza Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyLegionella Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyLyme Disease Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyLymphogranuloma Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMalaria Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMeasles Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMeningitis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMicrosporidium Test Volume and Diagnostics Sales Forecast
  17. 17. by Market SegmentGermanyMononucleosis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMumps Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyMycoplasma Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyPapilloma Virus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyParvovirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyPneumonia Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyPolyoma Viruses Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyPseudomonas Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyRabies Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyRSV Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyRhinovirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyRotavirus Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyRubella Test Volume and Diagnostics Sales Forecastby Market SegmentGermany
  18. 18. Salmonella Test Volume and Diagnostics Sales Forecastby Market SegmentGermanySepticemia Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyShigella Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyStaphylococci Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyStreptococci Test Volume and Diagnostics Sales Forecastby Market SegmentGermanySyphilis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyToxoplasmosis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyTrichomonas Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyTuberculosis Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyVibrio Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyWest Nile Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyYersinia Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyAIDS Testing Market Diagnostics Sales by Major SupplierGermanyCampylobacter Testing Market Diagnostics Salesby Major Supplier
  19. 19. GermanyCandida Testing Market Diagnostics Salesby Major SupplierGermanyCMV Testing Market Diagnostics Sales by Major SupplierGermanyEBV Testing Market Diagnostics Sales by Major SupplierGermanyGonorrhea Testing Market Diagnostics Salesby Major SupplierGermanyHepatitis Testing Market Diagnostics Salesby Major SupplierGermanyHepatitis C Testing Market Diagnostics Salesby Major SupplierGermanyHerpes Testing Market Diagnostics Salesby Major SupplierGermanyInfluenza Testing Market Diagnostics Salesby Major SupplierGermanyLegionella Testing Market Diagnostics Salesby Major SupplierGermanyMeningitis Testing Market Diagnostics Salesby Major SupplierGermanyMononucleosis Testing Market Diagnostics Salesby Major SupplierGermanyMycoplasma Testing Market Diagnostics Salesby Major SupplierGermanyPneumonia Testing Market Diagnostics Salesby Major SupplierGermanyRSV Testing Market Diagnostics Sales Forecastby Major SupplierGermany
  20. 20. Rotavirus Testing Market Diagnostics Salesby Major SupplierGermanyRubella Testing Market Diagnostics Salesby Major SupplierGermanySepticemia Testing Market Diagnostics Salesby Major SupplierGermanyStreptococci Testing Market Diagnostics Salesby Major SupplierGermanyToxoplasmosis Testing Market Diagnostics Salesby Major SupplierGermanyTrichomonas Testing Market Diagnostics Salesby Major SupplierGermanyTuberculosis Testing Market Diagnostics Salesby Major SupplierContact: sales@reportsandreports.com for more information.

×